CoChat

Use of Lipid-Lowering Therapies Over 2 Years in GOULD, a Registry of Patients With Atherosclerotic Cardiovascular Disease in the US

Open access
Cannon, Christopher P., de Lemos, James A., Rosenson, Robert S., Ballantyne, Christie M., Liu, Yuyin, Gao, Qi, Palagashvilli, Tamara, Alam, Shushama, Mues, Katherine E., Bhatt, Deepak L., Kosiborod, Mikhail N., GOULD Investigators, Knickelbine, Thomas, Augenbraun, Charles, Talano, James, Wahid, Faisal, Suh, David, Khant, Ranchhod, Aslam, Shamaila, Merryman, Scott, Herrington, David, Patel, Philip, Fox, Kenneth, Lamba, Sumant, Brodie, Steven, Sheth, Neil, Sheikh, Kahlid, Geltzer, Allen, Lillestol, Michael, Dave, Kamlesh, Koch, Stanley, Lupovitch, Steven, Piniella, Carlos, Allen, Lawrence, Vohra, Rakesh, Geller, Steven, Amin, Rohit, Michieli, Charles, Levin, Philip, Shammas, Nicolas, Potler, Andrew, Santos, Vladimir, Revana, Madaiah, Lader, Ellis, Strobl, David, Supple, Megan, Korpas, Denes, DeSantis, Donna, Fuchs-Ertman, Debra, Eid, Wael, Calhoun, Linda, Upadhyaya, Narendra, Cotter, Ryan, Maciejko, James, Ziajka, Paul, Smith, William, Antezano, Eduardo, O Donnell, Philip, Sloan, Lance, Wilson, Vance, Janosik, Denise, Kmetzo, James, Gangi, Sumana, Dharma, Chrisette, Godkar, Darshan, Nicol, Philip, Hong, Micheal, Popkin, Catherine, Patel, Rajesh, Vargas, Abelardo, Patel, Minesh, Desai, Vikas, Ma, Yunsheng, Block, Robert, Hiotis, Louis, Grossman, Colby, Arif, Ahmed, Baum, Seth, Sotolongo, Carlos, Jordan, Rebecca, Thompson, Paul, Napoli, Mark, Davidson, Robert, Durrence, Hugh, Aspry, Karen, Miller, Randall, Headley, David, Rothschild, Richard, Little, Raymond, Meisner, Carl, Powell, Richard, Moon, Eliot, Aggarwal, Kul, Turner, Mark, Acosta, Idalia, Schear, Martin, Harris, Robert, Lending, Robert, Salacata, Abraham, Kalen, Vicki, Bird, C David, Mbogua, Caroline, Duardo-Guerra, Yamirka, McMullen, Deirdre, Aazami, Hessam, Lovell, Charles, Busch, Robert, Janout, Marek, Alwine, Lawrence, Barbel Johnson, Kim, Dziko, Svjetlana, Larry, John, Cherian, Joseph, Allen, Gregory, Vargas, Faye, Zarich, Stuart, Ropero-Cartier, Armando, Samuel, Milroy, Khurana, Sandeep, Rodriguez Ables, Lilia, Gonzalez, Marisela, Nelson, Gregston, de Leon, Lester, Martinez, Luis, Badar, Francisco, Phiambolis, Thomas, Jaffrani, Naseem, Eck, John, Nowlan, Brett, Martin, Trever · 2021 · JAMA Cardiology
Cited by 243

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

Abstract

Importance: Guidelines for patients with atherosclerotic cardiovascular disease (ASCVD) recommend intensive statin therapy and adding nonstatin therapy if low-density lipoprotein cholesterol (LDL-C) levels are 70 mg/dL or more. Compliance with guidelines is often low. Objective: To track LDL-C treatment patterns in the US over 2 years. Design, Setting, and Participants: GOULD is a prospective observational registry study involving multiple centers. Patients with ASCVD receiving any lipid-lowering therapy (LLT) were eligible. Between December 2016 and July 2018, patients were enrolled in 1 of 3 cohorts: (1) those currently receiving proprotein convertase subtilisin/kexin type 9 inhibitor (PCSK9i) and 2 groups not receiving PCSK9i drugs, with (2) LDL-C levels of 100 mg/dL or more or (3) LDL-C levels of 70 to 99 mg/dL. Patients had medical record reviews and telephone interviews every 6 months. Analysis was done on data collected as of October 5, 2020. Main Outcomes and Measures: The primary outcome was the change in LLT use in 2 years. Secondary outcomes included the number of LDL-C measurements, LDL-C levels, and responses to structured physician and patient questionnaires over 2 years. Results: A total of 5006 patients were enrolled (mean [SD] age, 67.8 [9.9] years; 1985 women [39.7%]; 4312 White individuals [86.1%]). At 2 years, 885 (17.1%) had LLT intensification. In the cohorts with LDL-C levels of 100 mg/dL or more and 70 to 99 mg/dL, LLT intensification occurred in 403 (22.4%) and 383 (14.4%), respectively; statins were intensified in 115 (6.4%) and 168 (6.3%), ezetimibe added in 123 (6.8%) and 118 (4.5%), and PCSK9i added in 114 (6.3%) and 58 (2.2%), respectively. In the PCSK9i cohort, 508 of 554 (91.7%) were still taking PCSK9i at 2 years. Lipid panels were measured at least once over 2 years in 3768 patients (88.5%; PCSK9i cohort, 492 [96.1%]; LDL-C levels ≥100 mg/dL or more, 1294 [85.9%]; 70-99 mg/dL, 1982 [88.6%]). Levels of LDL-C fell from medians (interquartile ranges) of 120 (108-141) mg/dL to 95 (73-118) mg/dL in the cohort with LDL-C levels of 100 mg/dL or more, 82 (75-89) to 77 (65-90) mg/dL in the cohort with LDL-C levels of 70 to 99 mg/dL, and 67 (42-104) mg/dL to 67 (42-96) mg/dL in the PCSK9i cohort. Levels of LDL-C less than 70 mg/dL at 2 years were achieved by 308 patients (21.0%) and 758 patients (33.9%) in the cohorts with LDL-C levels of 100 mg/dL or more and 70 to 99 mg/dL, respectively, and 272 patients (52.4%) in the PCSK9i cohort. At 2 years, practice characteristics were associated with more LLT intensification (teaching vs nonteaching hospitals, 148 of 589 [25.1%] vs 600 of 3607 [16.6%]; lipid protocols or none, 359 of 1612 [22.3%] vs 389 of 2584 [15.1%]; cardiology, 452 of 2087 [21.7%] vs internal or family medicine, 204 of 1745 [11.7%] and other, 92 of 364 [25.3%]; all P < .001) and achievement of LDL-C less than 70 mg/dL (teaching vs nonteaching hospitals, 173 of 488 [35.5%] vs 823 of 2986 [27.6%]; lipid protocols vs none, 451 of 1411 [32.0%] vs 545 of 2063 [26.4%]; both P < .001; cardiology, 523 of 1686 [30.1%] vs internal or family medicine, 377 of 1472 [25.6%] and other, 96 of 316 [30.4%]; P = .003). Conclusions and Relevance: Of patients with ASCVD, most with suboptimal LDL-C levels at baseline, only 17.1% had LLT intensification after 2 years, and two-thirds remained at an LDL-C level greater than 70 mg/dL. Further intensive efforts are needed to achieve optimal LDL-C management in patients with ASCVD.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1001/jamacardio.2021.1810

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 12 references

Cited by

See all 243

Metadata

Authors
Cannon, C. P., de Lemos, J. A., Rosenson, R. S., Ballantyne, C. M., Liu, Y., Gao, Q., Palagashvilli, T., Alam, S., Mues, K. E., Bhatt, D. L., Kosiborod, M. N., GOULD Investigators, Knickelbine, T., Augenbraun, C., Talano, J., Wahid, F., Suh, D., Khant, R., Aslam, S., Merryman, S., Herrington, D., Patel, P., Fox, K., Lamba, S., Brodie, S., Sheth, N., Sheikh, K., Geltzer, A., Lillestol, M., Dave, K., Koch, S., Lupovitch, S., Piniella, C., Allen, L., Vohra, R., Geller, S., Amin, R., Michieli, C., Levin, P., Shammas, N., Potler, A., Santos, V., Revana, M., Lader, E., Strobl, D., Supple, M., Korpas, D., DeSantis, D., Fuchs-Ertman, D., Eid, W., Calhoun, L., Upadhyaya, N., Cotter, R., Maciejko, J., Ziajka, P., Smith, W., Antezano, E., O Donnell, P., Sloan, L., Wilson, V., Janosik, D., Kmetzo, J., Gangi, S., Dharma, C., Godkar, D., Nicol, P., Hong, M., Popkin, C., Patel, R., Vargas, A., Patel, M., Desai, V., Ma, Y., Block, R., Hiotis, L., Grossman, C., Arif, A., Baum, S., Sotolongo, C., Jordan, R., Thompson, P., Napoli, M., Davidson, R., Durrence, H., Aspry, K., Miller, R., Headley, D., Rothschild, R., Little, R., Meisner, C., Powell, R., Moon, E., Aggarwal, K., Turner, M., Acosta, I., Schear, M., Harris, R., Lending, R., Salacata, A., Kalen, V., Bird, C. D., Mbogua, C., Duardo-Guerra, Y., McMullen, D., Aazami, H., Lovell, C., Busch, R., Janout, M., Alwine, L., Barbel Johnson, K., Dziko, S., Larry, J., Cherian, J., Allen, G., Vargas, F., Zarich, S., Ropero-Cartier, A., Samuel, M., Khurana, S., Rodriguez Ables, L., Gonzalez, M., Nelson, G., de Leon, L., Martinez, L., Badar, F., Phiambolis, T., Jaffrani, N., Eck, J., Nowlan, B., & Martin, T.
Venue
JAMA Cardiology
Published
2021-09-01
Volume
6
Issue
9
Pages
1060
ISSN
2380-6583 (ISSN-L)
OpenAlex
W3170272938
Cited by
243
References
12
FWCI
28.60
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Use of Lipid-Lowering Therapies Over 2 Years in GOULD, a Registry of Patients With Atherosclerotic Cardiovascular Disease in the US. https://app.cochat.ai/papers/10.1001/jamacardio.2021.1810
The paper
Cannon, C. P., de Lemos, J. A., Rosenson, R. S., Ballantyne, C. M., Liu, Y., Gao, Q., Palagashvilli, T., Alam, S., Mues, K. E., Bhatt, D. L., Kosiborod, M. N., GOULD Investigators, Knickelbine, T., Augenbraun, C., Talano, J., Wahid, F., Suh, D., Khant, R., Aslam, S., . . . Martin, T. (2021). Use of Lipid-Lowering Therapies Over 2 Years in GOULD, a Registry of Patients With Atherosclerotic Cardiovascular Disease in the US. JAMA Cardiology. https://doi.org/10.1001/jamacardio.2021.1810

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.